Currently, artificial cornea and corneal implant market is projected to reach USD 599 million by 2026 from USD 418 million in 2021, at a CAGR of 7.4% from 2021 to 2026. The increasing prevalence of eye disorders and government initiatives to control visual impairment are further boosting the market growth. However, the high cost of ophthalmology devices and surgical procedures is expected to restrain the growth of this market during the forecast period. https://www.marketsandmarkets.com/requestsampleNew.asp?id=182165973 The prominent players operating in the Artificial Cornea and Corneal Implant Market are AJL Ophthalmic (Spain), CorneaGen Inc. (US), Addition Technology, Inc. (US), LinkoCare Life Sciences AB (Sweden), Presbia plc (Ireland), Mediphacos (Brazil), Aurolab (India), Cornea Biosciences (US), DIOPTEX GmbH (Austria), EyeYon Medical (Israel), Massachusetts Eye and Ear (US), Florida Lions Eye Bank (US), SightLife (US), Advancing Sight Network (US), San Diego Eye Bank (US) and L V Prasad Eye Institute (LVPEI, India).
Topics
